(Q40086665)

17 September 2017

1 reference

title

Clinical pharmacology of senile dementia (English)

1 reference

17 September 2017

M. Fisman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6122228

9 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6122228

9 August 2023

publication date

1 January 1981

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0364772281900266?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

https://api.elsevier.com/content/article/PII:0364772281900266?httpAccept=text/plain

9 August 2023

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Progress in Neuro-Psychopharmacology & Biological Psychiatry

9 August 2023

published in

1 reference

17 September 2017

5

1 reference

17 September 2017

447-457

1 reference

17 September 2017

5-6

1 reference

Effect of Cyclandelate on Perception, Memory and Cognition in a Group of Geriatric Subjects

17 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Effect of cyclandelate on mental function and cerebral blood flow in elderly patients.

9 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Progress towards stroke prevention: Robert Wartenberg lecture.

9 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Brain-decarboxylase activities as indices of pathological change in senile dementia.

9 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Clinical effects of choline in Alzheimer senile dementia

9 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Effects of chronic papaverine administration on mild senile organic brain syndrome

9 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Brain Acetylcholine: Control by Dietary Choline

9 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Electroencephalographic and Behavioral Changes Associated with Papaverine Administration in Healthy Geriatric Subjects

9 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Double-blind evaluation of naftidrofuryl in treating elderly confused hospitalised patients

9 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease

9 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Effect of papaverine on cerebral electrogenesis

9 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Selective loss of central cholinergic neurons in Alzheimer's disease

9 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains

9 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

9 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Senile dementia and Alzheimer's disease: a current view

9 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

The effect of magnesium pemoline on cognition and behavior.

9 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Clinical effects of choline in Alzheimer's disease

9 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Cognitive effects of ACTH 4-10 in the elderly

9 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Senile dementia: treatment with deanol

9 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Cyclandelate in the treatment of cerebral arteriosclerosis

9 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Prolongation of life: role of free radical reactions in aging

9 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature

9 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Levodopa in senile dementia.

9 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Naftidrofuryl--a double blind cross-over study in the elderly.

9 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Levodopa treatment of presenile dementia

9 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Trial of levodopa in senile dementia

9 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

9 August 2023

Q64818918

47

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

The quantitative assessment of lipofuscin pigment, cytoplasmic RNA and nucleolar volume in senile dementia

9 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

9 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Neurofibrillary pathology and protein synthetic capability in nerve cells in Alzheimer's disease

9 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Neurochemical findings in the aging brain

9 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Neurotransmitter Precursor Amino Acids in the Treatment of Multi-Infarct Dementia and Alzheimer's Disease†

9 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Deanol acetamidobenzoate inhibits the blood-brain barrier transport of choline

9 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Amantadine in senile dementia: electroencephalographic and clinical effects

9 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

RNA treatment of dementia. A double-blind study

9 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

9 August 2023

Vasopressin in amnesia

61

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

The extrapyramidal disorder of Alzheimer's disease.

9 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

9 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Bromocriptine in presenile dementia

9 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Anticoagulant Therapy for Senile Dementia*

9 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Diagnostic Accuracy in Presenile Dementia

9 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Mental decline in the elderly: pharmacotherapy (ergot alkaloids versus papaverine)

9 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia

9 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Influence of choline on amnesia in early Alzheimer's disease

9 August 2023

72

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

The cerebral lesions in a patient with generalized glutathione deficiency and pyroglutamic aciduria (5-oxoprolinuria)

9 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Management of chronic brain syndrome secondary to cerebral arteriosclerosis, with special reference to papaverine hydrochloride

9 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Observations on the brains of demented old people

9 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Presenile dementia: further experience with an anticoagulant-psychotherapy regimen.

9 August 2023

82

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Effect of Cyclandelate on Dementia

9 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Effects of vasopressin on human memory functions.

9 August 2023

84

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales

9 August 2023

85

1 reference

https://api.crossref.org/works/10.1016/0364-7722(81)90026-6

9 August 2023

Identifiers

1 reference

17 September 2017

1 reference